|
Dr. Miller received his Ph.D. in Human Biological Chemistry and Genetics from the University of Texas Medical Branch in Galveston, TX, and his M.B.A. from Santa Clara University in Santa Clara, CA. He performed postdoctoral fellowships at Scripps Clinic and Research Foundation in La Jolla, CA, and the University of California at Berkeley. He has over two decades of experience in the medical diagnostic, device, and pharmaceutical industries.
Before joining BAI in 2005, Dr. Miller was Senior Director of Business Development for Cardinal Health Pharmaceutical Development, responsible for sales in the Western United States. Prior to joining Cardinal Health, he was the chief executive officer of University Clinical Investigators, a clinical research and specialty laboratory company dedicated to diabetes treatment and study. Prior to joining UCII, he was the vice president of Research and Development for LXN Corporation, responsible for the development of a hand-held blood glucose and fructosamine monitor for diabetes. Dr. Miller has variously held senior positions in International Marketing and Sales, Research and Development, and Operations at Quidel Corporation, Biotrack (now Ciba Corning), MAST Immunosystems (now Hitachi Chemical Diagnostics, Inc.), and SmithKline Instruments (now Beckman Coulter Inc.).
Dr. Miller is responsible for the introduction of over 30 diagnostic products into the U.S. market and has over 20 scientific publications and 4 issued patents. | 